TMPRSS2 and aromatase were both increased in non-survivors and independently associated (p < 0.01) with mortality after adjusting for several baseline risk variables (including age, sex, CRP, hypertension, hyperlipidemia, and diabetes) in a multivariate logistic regression model. This evidence concerns the gene CYP19A1 and hyperlipidemia.